SeSA-HCPT: A dual-targeting agent that induces DNA damage and inhibits repair for castration-resistant prostate cancer therapy

Summary: Castration-resistant prostate cancer (CRPC) remains difficult to treat due to tumor heterogeneity and resistance. We developed SeSA-HCPT, a dual-targeting compound that links the topoisomerase I inhibitor hydroxycamptothecin (HCPT) with a selenium analog of the histone deacetylase (HDAC) in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yajie Wang, Qiuyu Wang, Li Meng, Xiaoying Lian, Xinyue Wu, Yuqing Wang, Tianyu Zhang, ShiLin Wei, Yanming Wang, Changjun Zhu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-02-01
coleção:	iScience
Assuntos:	Molecular biology Biotechnology Cancer
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2589004226001999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!